Director
DIN: 01874715
Sanjay Khandu Totare is currently associated with 2 companies as Director. They serve as a Director at YASHICA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01874715.Sanjay Khandu Totare has previously been associated with 1 company in roles such as Additional Director.Sanjay Khandu Totare is currently involved in 1 different role. Their most recent position is with PERIVINC PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Sanjay Khandu Totare was appointed to as a director was YASHICA PHARMACEUTICALS PRIVATE LIMITED. Sanjay Khandu Totare is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sanjay Khandu Totare is currently associated with 2 companies as Director. They serve as a Director at YASHICA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01874715.Sanjay Khandu Totare has previously been associated with 1 company in roles such as Additional Director.Sanjay Khandu Totare is currently involved in 1 different role. Their most recent position is with PERIVINC PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Sanjay Khandu Totare was appointed to as a director was YASHICA PHARMACEUTICALS PRIVATE LIMITED. Sanjay Khandu Totare is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
3y 9m 1y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| YASHICA PHARMACEUTICALS PRIVATE LIMITED | Director | 15-Nov-2007 |
| PERIVINC PHARMACEUTICALS PRIVATE LIMITED | Director | 25-Jun-2018 |